Clinical Trials Browser

Phase 2/3 × Melanoma × molgramostim × Clear all

NCT01729663 2015-09-02

Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients

Phase 2/3 Unknown

Melanoma